Mats Wahlstrom, Director, 10% Owner at TriSalus Life Sciences, Inc. (TLSI), bought 10,727 shares at $4.44 ($47K) on 2024-11-21, disclosed to the SEC on 2024-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.16 | 2,040 | $8K | 18.0% |
| 2 | $4.44 | 8,687 | $39K | 82.0% |
| Total | $4.39 avg | 10,727 | $47K | 100% |
| Filing → |
| TLSI | BUY | 2024-11-25 | $23K | — | Filing → |
| CHRS | SELL | 2020-06-19 | $6.9M | — | Filing → |
| CHRS | SELL | 2020-03-05 | $4.8M | — | Filing → |